lung-cancer

Documents about lung-cancer

• SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer#287545ClinicalTrials.gov
• Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)#172370ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer#195393ClinicalTrials.gov
• Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging#222408ClinicalTrials.gov
• Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer#249582ClinicalTrials.gov
• Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer#398303ClinicalTrials.gov
• Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer#424245ClinicalTrials.gov
• The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)#174856ClinicalTrials.gov
• Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer#123479ClinicalTrials.gov
• DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs#127576ClinicalTrials.gov
• Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma#377405ClinicalTrials.gov
• IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.#387150ClinicalTrials.gov
• Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer#432872ClinicalTrials.gov
• Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.#287552ClinicalTrials.gov
• Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer#146435ClinicalTrials.gov
• Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer#180406ClinicalTrials.gov
• A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)#268015ClinicalTrials.gov
• Cancer Statistics, 2009#7189OpenAlex
• Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)#152389ClinicalTrials.gov
• Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)#321708ClinicalTrials.gov
• Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer#141081ClinicalTrials.gov
• Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB#195298ClinicalTrials.gov
• Lung cancer screening in transition: highlights from the 3rd Oslo Lung Cancer Symposium, 2025.#214153NCBI PubMed Central
• Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)#238124ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer#287372ClinicalTrials.gov
• irAE Prediction of Anti-PD-1/L1 in Lung Cancer#346927ClinicalTrials.gov
• Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer#407730ClinicalTrials.gov
• Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer#424241ClinicalTrials.gov
• Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer#432894ClinicalTrials.gov
• Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer#435724ClinicalTrials.gov
• Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy#141093ClinicalTrials.gov
• A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer#180385ClinicalTrials.gov
• Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer#373585ClinicalTrials.gov
• Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer#390953ClinicalTrials.gov
• Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer#424231ClinicalTrials.gov
• Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2#444859ClinicalTrials.gov
• Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer#174886ClinicalTrials.gov
• Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers#366602ClinicalTrials.gov
• Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer#160159ClinicalTrials.gov
• Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer#343837ClinicalTrials.gov
• Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2#338826OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study#143577ClinicalTrials.gov
• Liquid BiOpsy, Lung and Colon Cancer in AndaluciA#195316ClinicalTrials.gov
• Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer#245516ClinicalTrials.gov
• Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer#253066ClinicalTrials.gov
• Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer#67899ClinicalTrials.gov
• Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer#121367ClinicalTrials.gov
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer#238093ClinicalTrials.gov
• Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung Cancer#245498ClinicalTrials.gov
• Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer#261527ClinicalTrials.gov